Retina Gallery ~ Full Sized Retina Images

Rapid severe macular atrophy with ranibizumab therapy for myopic CNVM 64 year old female with vision loss and distortion in the right and better eye from CNVM. Vision on presentation was 20/32 right eye and 3/200 left eye. She was treated with monthly Lucentis and the vision in the right eye declined to 20/200 in one year. Treatment was stopped and the vision improved to 20/80
Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 35564 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 37464 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 35764 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 37864 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)
Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 34264 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 34564 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 37564 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 32864 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)
Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 34864 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 33164 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 34064 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 34264 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)
Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 35364 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 37464 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 35364 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 34364 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)
Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 35564 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 32364 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 35264 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 32864 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)
Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 39564 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 33364 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 33664 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 38264 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)
Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 33464 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 34664 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 35264 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 34064 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)
Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 34364 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 33364 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 34164 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 32964 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)
Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 32664 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 35164 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 32164 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 37064 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)
Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 34164 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 36364 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 34164 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)	Rapid macular atrophy with anti-VEGF therapy for myopic CNVMvaatamisi: 31664 year old female with 20/32 vision and distortion in the left and better eye. She was treated with monthly lucentis and her vision declined to 20/100. Medicine was stopped and she improved a little to 20/80. (0 hinnangut)
40 faili 1 lehel

64 year old female with vision loss and distortion in the right and better eye from CNVM. Vision on presentation was 20/32 right eye and 3/200 left eye. She was treated with monthly Lucentis and the vision in the right eye declined to 20/200 in one year. Treatment was stopped and the vision improved to 20/80